- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Growth Stocks
U.S. Pharmaceuticals & Biotech High Growth Stocks
Results
5
High Growth Stocks
5 companies
SIGA Technologies
Market Cap: US$422.2m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.08
7D
-1.9%
1Y
-20.3%
Krystal Biotech
Market Cap: US$3.6b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$126.45
7D
-3.9%
1Y
-20.5%
Harmony Biosciences Holdings
Market Cap: US$2.0b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$33.79
7D
-5.1%
1Y
14.9%
Neurocrine Biosciences
Market Cap: US$11.9b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$122.64
7D
-0.3%
1Y
-12.7%
Aurinia Pharmaceuticals
Market Cap: US$1.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$8.15
7D
-1.8%
1Y
54.1%